Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Arterial Disease Multifactorial Intervention Trial (ADMIT)

NCT00000539 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT00000539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00000539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Arterial Disease Multifactorial Intervention Trial (ADMIT)
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Phase 3
Overall status
Completed
Start date
September 30, 1992
Completion date
March 31, 1999
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

arterial occlusive diseases, cardiovascular diseases, diabetes mellitus, heart diseases, vascular diseases